StudyGovernment health research
- Source type
- Study
- Access type
- Abstract/index
- Publisher
- PubMed
- Indexed by
- PubMed
- Date
- 2023
- Added
- 2026-06-19
Trust profile
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
Primary sourcesignal2 references
GLP-1s Are Not Just a Weight Loss Story
Roles: Primary source
Show section-level references
Primary sourcestudy1 reference
Semaglutide and cardiovascular outcomes in obesity without diabetes
Roles: Primary source
Show section-level references
Claims supported
- Semaglutide reduced major adverse cardiovascular events in SELECT participants with overweight or obesity and established cardiovascular disease without diabetes.
Related studies
Related sources
GovernmentU.S. health regulator
FDA approves Wegovy to reduce risk of serious heart problems in adults with obesity or overweight and cardiovascular disease
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 6 connections
StudyPeer-reviewed research publisher
Long-term weight loss effects of semaglutide in obesity without diabetes in SELECT
Nature Medicine used across the Viral Vitalism evidence library.
- Trust score
- 88
- Publisher
- Nature Medicine
- Access
- Publisher
- Usage
- 3 connections
StudyPeer-reviewed research publisher
Semaglutide and cardiovascular outcomes in obesity without diabetes
New England Journal of Medicine used across the Viral Vitalism evidence library.
- Trust score
- 88
- Publisher
- New England Journal of Medicine
- Access
- Publisher
- Usage
- 5 connections
Trial registryClinical trial registry
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
Topic tags
glp-1semaglutideselectcardiovascular-risk